DE602005025231D1 - Gene und polypeptide in verbindung mit brustkrebserkrankungen - Google Patents

Gene und polypeptide in verbindung mit brustkrebserkrankungen

Info

Publication number
DE602005025231D1
DE602005025231D1 DE602005025231T DE602005025231T DE602005025231D1 DE 602005025231 D1 DE602005025231 D1 DE 602005025231D1 DE 602005025231 T DE602005025231 T DE 602005025231T DE 602005025231 T DE602005025231 T DE 602005025231T DE 602005025231 D1 DE602005025231 D1 DE 602005025231D1
Authority
DE
Germany
Prior art keywords
breast cancer
genes
polypeptides
connection
cancer diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005025231T
Other languages
English (en)
Inventor
Yusuke Nakamura
Toyomasa Katagiri
Shuichi Nakatsuru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncotherapy Science Inc
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of DE602005025231D1 publication Critical patent/DE602005025231D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602005025231T 2004-08-10 2005-07-29 Gene und polypeptide in verbindung mit brustkrebserkrankungen Active DE602005025231D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60014604P 2004-08-10 2004-08-10
PCT/JP2005/014369 WO2006016525A2 (en) 2004-08-10 2005-07-29 Genes and polypeptides relating to breast cancers

Publications (1)

Publication Number Publication Date
DE602005025231D1 true DE602005025231D1 (de) 2011-01-20

Family

ID=35063162

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005025231T Active DE602005025231D1 (de) 2004-08-10 2005-07-29 Gene und polypeptide in verbindung mit brustkrebserkrankungen

Country Status (8)

Country Link
US (1) US20090263395A1 (de)
EP (1) EP1786925B1 (de)
JP (1) JP5028601B2 (de)
CN (1) CN101068935B (de)
AT (1) ATE491044T1 (de)
DE (1) DE602005025231D1 (de)
ES (1) ES2357658T3 (de)
WO (1) WO2006016525A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI466680B (zh) 2008-08-01 2015-01-01 Oncotherapy Science Inc Ｍｅｌｋ抗原決定位胜肽及含此胜肽的疫苗
TWI485245B (zh) 2010-01-25 2015-05-21 Oncotherapy Science Inc 經修飾之ｍｅｌｋ胜肽及含此胜肽之疫苗
BR112013002182B8 (pt) 2010-07-30 2023-02-28 Oncotherapy Science Inc Compostos derivados de quinolina, composição farmacêutica, inibidor de melk, agente modulador de expressão de melk, agente antitumor, agente terapêutico e/ou preventivo para uma doença que envolve a superexpressão de melk contendo os mesmos e uso dos referidos compostos
TWI623537B (zh) 2012-01-19 2018-05-11 腫瘤療法 科學股份有限公司 １,５-萘啶衍生物與含此之ｍｅｌｋ抑制劑
MX2019002269A (es) 2016-08-31 2019-09-18 Oncotherapy Science Inc Anticuerpo monoclonal contra quinasa de cremallera de leucina embrionaria materna (melk) y utilizacion del mismo.
NL2020004B1 (en) 2016-12-09 2018-07-02 Ary Flohil Jacob Treatment of diffuse intrinsic pontine glioma
CN108997488B (zh) * 2018-08-14 2021-07-30 湖南师范大学 具有抗乳腺癌活性的间斑寇蛛卵粒蛋白质及其制法与应用
CN109929808B (zh) * 2019-04-02 2020-10-16 中国医学科学院医药生物技术研究所 以line-1 orf1蛋白为靶点的抗癌药物筛选模型及筛选方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100209784B1 (ko) * 1996-10-08 1999-07-15 박원훈 인간 단백질 변이인산화효소 유전자(hpk 38), 그의 염기 서열, 효소 단백질 및 그의 아미노산 서열
PT1292289E (pt) * 2000-05-31 2008-04-23 Novartis Vaccines & Diagnostic Composições e métodos para tratar doença neoplásica utilizando sensibilizadores de quimioterapia e radiação
US20020156263A1 (en) * 2000-10-05 2002-10-24 Huei-Mei Chen Genes expressed in breast cancer
AU2003225535A1 (en) * 2002-01-31 2003-09-02 Millennium Pharmaceuticals, Inc. Methods and compositions for treating cancer
TW200413725A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
DK1641810T4 (en) * 2003-06-24 2017-07-03 Genomic Health Inc Predicting the likelihood of cancer recurrence
CA2535808A1 (en) * 2003-08-14 2005-02-24 Exelixis, Inc. Melks as modifiers of the rac pathway and methods of use

Also Published As

Publication number Publication date
EP1786925A2 (de) 2007-05-23
JP5028601B2 (ja) 2012-09-19
CN101068935B (zh) 2012-06-27
JP2008509652A (ja) 2008-04-03
EP1786925B1 (de) 2010-12-08
WO2006016525A2 (en) 2006-02-16
CN101068935A (zh) 2007-11-07
ES2357658T3 (es) 2011-04-28
ATE491044T1 (de) 2010-12-15
WO2006016525A3 (en) 2006-07-06
US20090263395A1 (en) 2009-10-22

Similar Documents

Publication Publication Date Title
DE602005025231D1 (de) Gene und polypeptide in verbindung mit brustkrebserkrankungen
DE60336227D1 (de) Gene und proteine mit bezug zu menschlichem kolonkrebs
TNSN05300A1 (en) Treatment with anti-vegf antibodies
EP3064509A3 (de) Anti-angiogenese-therapie für die behandlung von ovarialkarzinom
WO2008093165A3 (en) The use of pgil ohgosaccharyltransferase for o-glycosylating proteins
NO20070950L (no) Preparater og fremgangsmater for anvendelse av angiopoietinlignende-4-protein.
DE60208397D1 (de) Valproinsäure zur Behandlung von Brustkrebs, Dickdarmkrebs, Kopf-Hals-Krebs, kleinzelligem Lungenkarzinom und Blutzellenkrebs in Kombination mit Bestrahlung
EA201000644A1 (ru) Антитела для лечения и профилактики болезни альцгеймера и их применение
DE602005026789D1 (de) Le
SG158112A1 (en) Hepatocyte growth factor (hgf) binding proteins
EA200601946A3 (ru) Антитела, связывающиеся с белками steap-1, и их производные
MX340724B (es) Terapia anti-angiogenesis para el tratamiento del cancer de mama.
WO2007015935A3 (en) Diagnostic methods for the prediction of therapeutic success, recurrence free and overall survival in cancer therapy
AR026946A1 (es) Osteoprotegerina/receptores de factores de necrosis de tumores
WO2006027693A8 (en) Tumor specific genes and variant rnas and uses thereof as targets for cancer therapy and diagnosis
DK2041576T3 (da) Differentiel cytokinekspression i humane cancere
MX2021010288A (es) Expansion de linfocitos infiltrantes de tumores a partir de tumores liquidos y usos terapeuticos de los mismos.
Yang et al. Roles of protein disulfide isomerase in breast cancer
Albu et al. Borderline Brenner tumors associated with ovarian cyst-case presentation
PL1869185T3 (pl) Koniugat zawierający białko P21 do leczenia raka
AR073218A1 (es) Anticuerpo antineuropilina 2 humano, induccion de la expresion del gen supresor de tumores p53 por la neutralizacion de la neuropilina 2 para el tratamiento de cancer
WO2007013479A3 (en) Genes and polypeptides relating to prostate cancers
Johansson et al. Remodeling of tumor stroma and response to therapy
EA200701894A1 (ru) Уровень транскрипции гена timp3 в качестве диагностического маркера немелкоклеточного рака легких
WO2007013670A3 (en) Gene galnt6 as breast cancer marker and small interfering rnas directed against gene galnt6